Haplotype structure and selection of the MDM2 oncogene in humans

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 11, 2007, Pages 4524-4529

  Atwal, Gurinder Singh ^a   Bond, Gareth L ^a   Metsuyanim, Sally ^c   Papa, Moshe ^c   Friedman, Eitan ^c   Distelman Menachem, Tal ^c   Asher, Edna Ben ^d   Lancet, Doron ^d   Ross, David A ^e   Sninsky, John ^e   White, Tomas J ^e   Levine, Arnold J ^a,b   Yarden, Ronit ^c  

^a INSTITUTE FOR ADVANCED STUDY   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^d WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^e CELERA   (United States)

Author keywords

Cancer; Entropy; p53; Population genetics; SNP

Indexed keywords

PROTEIN MDM2; PROTEIN P53; UBIQUITIN PROTEIN LIGASE; MDM2 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

AFRICAN AMERICAN; ALLELE; ARTICLE; CANCER RISK; CAUCASIAN; ENTROPY; ETHNIC GROUP; GENE FREQUENCY; GENE STRUCTURE; HAPLOTYPE; HUMAN; JEW; MDM2 ONCOGENE; ONCOGENE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE; BIOLOGICAL MODEL; GENE LINKAGE DISEQUILIBRIUM; GENETICS; GENOTYPE; METABOLISM; MONTE CARLO METHOD; NEGRO; PHYSIOLOGY;

AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; ENTROPY; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; JEWS; LINKAGE DISEQUILIBRIUM; MODELS, GENETIC; MONTE CARLO METHOD; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34248387347     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0610998104     Document Type: Article

References (38)

1. Jin S, Levine AJ (2001) J Cell Sci 114:4139-4140.
2. Lain S, Lane D (2003) Eur J Cancer 39:1053-1060.
3. Bond GL, Hu W, Levine AJ (2005) Curr Cancer Drug Targets 5:3-8.
4. Murphy ME (2006) Cell Death Differ 13:916-920.
5. Bonafe M, Salvioli S, Barbi C, Mishto M, Trapassi C, Gemelli C, Storci G, Olivieri F, Monti D, Franceschi C (2002) Biochem Biophys Res Commun 299:539-541.
6. Dumont P, Leu JI, Delia Pietra AC. Ill, George DL, Murphy M (2003) Nat Genet 33:357-365.
7. Sullivan A, Syed N, Gasco M, Bergamaschi D, Trigiante G, Attard M, Hiller L, Farrell PJ, Smith P, Lu X, Crook T (2004) Oncogene 23:3328-3337.
8. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G (1999) Mol Cell Biol 19:1092-1100.
9. Jones JS, Chi X, Gu X, Lynch PM, Amos CI, Frazier ML (2004) Clin Cancer Res 10:5845-5849.
10. Shen H, Zheng Y, Sturgis EM, Spitz MR, Wei Q (2002) Cancer Lett 183:123-130.
11. Bond GL, Hu W, Bond EE, Robins H, Lutzker SG, Arva NC, Bargonetti J, Bartel F, Taubert H, Wuerl P, et al. (2004) Cell 119:591-602.
12. Alhopuro P, Ylisaukko-Oja SK, Koskinen WJ, Bono P, Arola J, Jarvinen HJ, Mecklin JP, Atula T, Kontio R, Makitie AA, et al. (2005) J Med Genet 42:694-698.
13. Arva NC, Gopen TR, Talbott KE, Campbell LE, Chicas A, White DE, Bond GL, Levine AJ, Bargonetti J (2005) J Biol Chem 280:26776-26787.
14. Bond GL, Hirshfield KM, Kirchhoff T, Alexe G, Bond EE, Robins H, Bartel F, Taubert H, Wuerl P, Halt W, et al. (2006) Cancer Res 66:5104-5110.
15. Bougeard G, Baert-Desurmont S, Tournier I, Vasseur S, Martin C, Brugieres L, Chompret A, Bressae-de Paillerets B, Stoppa-Lyonnet D, Bonaiti-Pellie C, Frebourg T (2005) J Med Genet 43:531-533.
16. Hong Y, Miao X, Zhang X, Ding F, Luo A, Guo Y, Tan W, Liu Z, Lin D (2005) Cancer Res 65:9582-9587.
17. Lind H, Zienolddiny S, Ekstrom PO, Skaug V, Haugen A (2006) Int J Cancer 119:718-721.
18. Menin C, Scaini MC, De Salvo GL, Biscuola M, Quaggio M, Esposito G, Belluco C, Montagna M, Agata S, D'Andrea E, et al. (2006) J Natl Cancer Inst 98:285-288.
19. Swinney RM, Hsu SC, Hirschman BA, Chen TT, Tomlinson GE (2005) Leukemia 19:1996-1998.
20. Zhang X, Miao X, Guo Y, Tan W, Zhou Y, Sun T, Wang Y, Lin D (2005) Hum Mutat 27:110-117.
21. Dharel N, Kato N, Muroyama R, Moriyama M, Shao RX, Kawabe T, Omata M (2006) Clin Cancer Res 12:4867-4871.
22. Park SH, Choi JE, Kim EJ, Jang JS, Han HS, Lee WK, Kang YM, Park JY (2006) Lung Cancer 54:19-24.
23. Bond GL, Menin C, Bertorelle R, Alhorpuro P, Aaltonen LA, Levine AJ (2006) J Med Genet 43:950-952.
24. Harris SL, Gil G, Robins H, Hu W, Hirshfield K, Bond E, Bond G, Levine AJ (2005) Proc Natl Acad Sci USA 102:16297-16302.
25. Millikan RC, Heard K, Winkel S, Hill EJ, Heard K, Massa B, Mayes L, Williams P, Holston R, Conway K, Edmiston S, de Cotret AR (2006) Cancer Epidemiol Biomarkers Prev 15:175-177.
26. Excoffier L, Laval G, Schneider S (2005) 1:47-50.
27. Cover TM, Thomas JA (1991) Elements of Information Theory (Wiley, New York).
28. Strong SP, Koberle, R., de Ruyter van Steveninek RR, Bialek W (1998) Phys Rev Lett 80:197.
29. Hudson RR (2002) Bioinformatics 18:337-338.
30. Spencer CCA, Coop G (2004) Bioinformatics 20:3673-3675.
31. Sabeti PC, Reich DE, Higgins JM, Levine HZ, Richter DJ, Schaffner SF, Gabriel SB, Platko JV, Patterson NJ, McDonald GJ, et al. (2002) Nature 419:832-837.
32. Voight BF, Kudaravalli S, Wen X, Pritchard JK (2006) PLoS Biol 4:3.
33. Beckman G, Birgander R, Sjalander A, Saha N, Holmberg PA, Kivela A, Beckman L (1994) Hum Hered 44:266-270.
34. Choi J, Donehower LA (1999) Cell Mol Life Sci 55:38-47.
35. Lozano G, Liu G (1998) Semin Cancer Biol 8:337-344.
36. Germer S, Holland MJ, Higuchi R (2000) Genome Res 10:258-266.
37. Stephens M, Smith NJ, Donnelly P (2001) Am J Hum Genet 68:978-989.
38. Guo SW, Thompson EA (1992) Biometrics 48:361-372.